LUND, Sweden, June 9, 2025 /PRNewswire/ -- Hansa Biopharma AB, "Hansa" (Nasdaq Stockholm: HNSA) today announced that it will host a virtual investor event on Guillain-Barré syndrome (GBS) on Monday, June 16, 2025 at 14:00 CEST / 8:00 AM EDT. Pre-registration is required and can be found...
Hence then, the article about hansa biopharma to host science deep dive virtual investor event on guillain barre syndrome on june 16 2025 was published today ( ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.
Read More Details
Finally We wish PressBee provided you with enough information of ( Hansa Biopharma to Host Science Deep Dive Virtual Investor Event on Guillain-Barré Syndrome on June 16, 2025 )
Also on site :
- South Africa pushes for renewable energy investment
- Zelensky is ‘a man in a desperate position’ – Orban
- SeaWorld in Texas Is Opening a First-of-Its-Kind Inverted Coaster This Spring